Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry R Colca

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Expert Opinion on Investigational Drugs|June 18, 2015
Discontinued drug therapies to treat diabetes in 2014Jerry R Colca
Expert Opinion on Investigational Drugs|August 22, 2013
Discontinued drugs in 2012: endocrine and metabolicJerry R Colca
Biochemical Pharmacology|February 14, 2006
Insulin sensitizers may prevent metabolic inflammationJerry R Colca
Current Opinion in Investigational Drugs (London, England : 2000)|August 31, 2007
Future directions for insulin sensitizers in disease preventionJerry R Colca
Expert Opinion on Investigational Drugs|January 25, 2007
Discontinued drugs in 2005: endocrine and metabolicJerry R Colca
Expert Opinion on Investigational Drugs|October 17, 2008
Discontinued drug in 2007: renal, endocrine and metabolic drugsJerry R Colca
Expert Opinion on Drug Discovery|October 20, 2015
The TZD insulin sensitizer clue provides a new route into diabetes drug discoveryJerry R Colca
Expert Opinion on Investigational Drugs|October 10, 2007
Discontinued drugs in 2006: renal, endocrine and metabolic drugsJerry R Colca
Expert Opinion on Investigational Drugs|October 10, 2007
67 th annual meeting of the American Diabetes AssociationJerry R Colca
Expert Opinion on Investigational Drugs|August 15, 2009
Discontinued drugs in 2008: endocrine and metabolicJerry R Colca
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Expert Opinion on Investigational Drugs|June 18, 2015
Discontinued drug therapies to treat diabetes in 2014Jerry R Colca
Expert Opinion on Investigational Drugs|August 22, 2013
Discontinued drugs in 2012: endocrine and metabolicJerry R Colca
Biochemical Pharmacology|February 14, 2006
Insulin sensitizers may prevent metabolic inflammationJerry R Colca
Current Opinion in Investigational Drugs (London, England : 2000)|August 31, 2007
Future directions for insulin sensitizers in disease preventionJerry R Colca
Expert Opinion on Investigational Drugs|January 25, 2007
Discontinued drugs in 2005: endocrine and metabolicJerry R Colca
Expert Opinion on Investigational Drugs|October 17, 2008
Discontinued drug in 2007: renal, endocrine and metabolic drugsJerry R Colca
Expert Opinion on Drug Discovery|October 20, 2015
The TZD insulin sensitizer clue provides a new route into diabetes drug discoveryJerry R Colca
Expert Opinion on Investigational Drugs|October 10, 2007
Discontinued drugs in 2006: renal, endocrine and metabolic drugsJerry R Colca
Expert Opinion on Investigational Drugs|October 10, 2007
67 th annual meeting of the American Diabetes AssociationJerry R Colca
Expert Opinion on Investigational Drugs|August 15, 2009
Discontinued drugs in 2008: endocrine and metabolicJerry R Colca
Pageof 5